logo

BIOL’s Financial Health: Exploring Biolase Inc’s Debt-to-Equity Ratio of 1.79

Biolase Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $47.10 on 04/19/23, with the lowest value being $0.13 on 03/08/24.

52-week price history of BIOL Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Biolase Inc’s current trading price is -99.64% away from its 52-week high, while its distance from the 52-week low is 35.33%. The stock’s price range during this period has fluctuated between $0.13 and $47.10. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.99 million for the day, which was evidently lower than the average daily volume of 5.47 million over the last three months.

Financial Performance and Market Capitalization

Biolase Inc (BIOL) has experienced a quarterly decline of -84.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.51M and boasts a workforce of 157 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7129, with a change in price of -1.2607. Similarly, Biolase Inc recorded 3,500,828 in trading volume during the last 100 days, posting a change of -88.16%.

BIOL Stock Stochastic Average

Biolase Inc’s raw stochastic average for the past 50 days is currently at 5.49%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 33.51%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 38.26% and 41.70%, respectively.

BIOL Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -84.91% this year. Over the last six months, there has been a stronger performance of -90.75%. The price of BIOL fallen by 20.07% during the last 30 days period. For the last 5-days stocks have slided -10.80%.